Related Experiment Video
Updated: May 28, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Beyond Stenosis: Mechanism-Based Multimodality Imaging and Invasive Coronary Function Testing for Endotype Definition
Lucio Giuseppe Granata1, Marcello Marchetta2, Simona Giubilato3
1Cardiology Division, Garibaldi-Nesima Hospital, ARNAS Garibaldi, 95122 Catania, Italy.
Insights
Ischaemia with no obstructive coronary artery disease (INOCA) is linked to coronary vascular dysfunction. A mechanism-based diagnostic strategy using multimodality imaging and invasive testing helps define the coronary endotype for targeted therapy.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Vascular Medicine
Background:
- Angina or objective myocardial ischaemia in the absence of obstructive coronary artery disease (ANOCA/INOCA) is common, causing symptoms and reduced quality of life.
- Contemporary evidence identifies these syndromes as manifestations of coronary vascular dysfunction, including microvascular and epicardial issues.
- Current diagnostic approaches often lack a structured, mechanism-based strategy for defining the underlying coronary endotype.
Purpose of the Study:
- To propose a structured, mechanism-based diagnostic strategy for ANOCA/INOCA.
- To integrate anatomical, perfusion, and functional testing for comprehensive coronary characterization.
- To link diagnostic findings to targeted therapy through an endotype-driven approach.
Main Methods:
- Review of contemporary evidence on coronary vascular dysfunction and diagnostic modalities.
- Emphasis on multimodality imaging (CT angiography, PET, CMR) and invasive coronary function testing (ICFT).
- Integration of anatomical assessment, quantitative perfusion imaging, and ICFT (coronary flow reserve, microvascular resistance, acetylcholine testing).
Main Results:
- A shift from a stenosis-centred to a physiology- and mechanism-based approach is recommended.
- Multimodality imaging and ICFT enable comprehensive characterization of coronary physiology and vasomotor function.
- A pragmatic framework linking diagnostic findings to targeted therapy is proposed.
Conclusions:
- Endotype-driven management of ANOCA/INOCA can close the gap between diagnosis and treatment.
- A structured, mechanism-based diagnostic strategy improves patient outcomes.
- This approach facilitates targeted therapy for ischaemia with no obstructive coronary artery disease.
Abstract:
Angina or objective myocardial ischaemia in the absence of obstructive coronary artery disease, referred to as ANOCA/INOCA, represents a prevalent and clinically significant condition associated with persistent symptoms, impaired quality of life, and increased healthcare utilisation. Contemporary evidence has reframed these syndromes as manifestations of coronary vascular dysfunction, encompassing structural and functional coronary microvascular dysfunction, epicardial vasospasm, microvascular spasm, and mixed phenotypes. In this context, multimodality imaging should not be conceptualised as sequential test accumulation, but rather as a structured, mechanism-based diagnostic strategy aimed at defining the underlying coronary endotype. The 2024 ESC Guidelines for chronic coronary syndromes endorse dedicated diagnostic pathways beyond a stenosis-centred paradigm and support the use of invasive coronary function testing (ICFT) in selected patients with persistent symptoms or inconclusive non-invasive findings. An integrated approach combining anatomical assessment (coronary computed tomography angiography or invasive angiography ± pressure-based indices), quantitative perfusion imaging (positron emission tomography or stress cardiovascular magnetic resonance), and ICFT (including coronary flow reserve, microvascular resistance indices, and acetylcholine provocation testing) enables comprehensive characterisation of coronary physiology and vasomotor function. This review proposes a pragmatic framework linking diagnostic findings to targeted therapy through a test-to-endotype-to-therapy paradigm. We summarise the strengths and limitations of each modality, discuss implementation challenges, and highlight the clinical relevance of endotype-driven management. By shifting from a stenosis-centred to a physiology- and mechanism-based approach, this strategy has the potential to close the longstanding gap between diagnosis and treatment in patients with ischaemia beyond obstructive coronary disease.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT
Aneurysm II: Clinical Manifestations and Diagnostic Studies